✦ LIBER ✦

A Phase IIIb Study to Evaluate the Safety of Ranibizumab in Subjects with Neovascular Age-related Macular Degeneration

✍ Scribed by David S. Boyer; Jeffrey S. Heier; David M. Brown; Steven F. Francom; Tsontcho Ianchulev; Roman G. Rubio

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Subgroup Analysis of the MARINA Study of

✍ David S. Boyer; Andrew N. Antoszyk; Carl C. Awh; Robert B. Bhisitkul; Howard Sha 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 815 KB

A safety evaluation of ranibizumab in th

✍ Gibson, Jonathan Mark; Gibson, Stewart James 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 270 KB

Safety and Efficacy of a Flexible Dosing

✍ Frank G. Holz; Winfried Amoaku; Juan Donate; Robyn H. Guymer; Ulrich Kellner; Re 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 687 KB

Efficacy and Safety of Monthly versus Qu

✍ Ursula Schmidt-Erfurth; Bora Eldem; Robyn Guymer; Jean-François Korobelnik; Rein 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 985 KB

Ranibizumab for Treatment of Neovascular

✍ Jeffrey S. Heier; Andrew N. Antoszyk; Peter Reed Pavan; Steven R. Leff; Philip J 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 311 KB

Ranibizumab for Treatment of Neovascular

✍ Jeffrey S. Heier; Andrew N. Antoszyk; Peter Reed Pavan; Steven R. Leff; Philip J 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 311 KB